Catheter surface technology and urethral health

Here, we review a recent paper published in the European Medical Journal – ‘From Lubricity to Surface Integrity: Expert Perspectives on Polyvinylpyrrolidone-Coated Intermittent Catheters’. EMJ 2026 11(3): 37–49.

A recent paper published in the European Medical Journal (Kenelly et al, 2026) saw a global panel of experts exploring the benefits and potential limitations of polyvinylpyrrolidone (PVP)-coated hydrophilic intermittent catheters, alongside an innovative technology known as integrated amphiphilic surfactant (IAS). Through interviews with a multidisciplinary panel of healthcare professionals and a review of preclinical research, the authors consider how catheter surface properties may affect comfort, urethral tissue integrity and the overall experience of intermittent catheterisation (IC) for catheter users.

IC is an established method of bladder management for people with conditions such as spinal cord injury, multiple sclerosis and other causes of bladder dysfunction. As catheterisation may be performed several times a day over many years, catheter design is important for ease of insertion, comfort and urethral health.

The following key themes arose from the expert panel discussion. 
 


Hydrophilic catheters: an important development


PVP-coated hydrophilic catheters have improved the experience of IC because they reduce friction when hydrated, making insertion easier than with uncoated catheters which require separate lubrication. The paper acknowledges the established benefits of hydrophilic catheter technology, but questions whether all hydrophilic surfaces perform equally well throughout catheterisation.
 
Catheter surface technology and urethral health
Photograph: gas pil/Shutterstock

Potential limitations of PVP coatings


The authors discuss reports of catheter sticking during withdrawal, pulling sensations, discomfort, pain and bleeding. They also review preclinical studies suggesting that some PVP-coated catheters may become more adhesive as their hydration decreases. Findings included increased adhesion to tissue, disruption of urothelial cells and deposition of coating residues in urethral models.

However, the authors also recognise that these findings vary between products and that many people use PVP-coated catheters successfully without significant problems.

 

Possible implications for urinary tract health and fertility


The paper considers whether interactions between PVP residues and urethral tissue could contribute to inflammation or tissue damage, with possible implications for urinary tract infection (UTI). However, clinical studies have not established whether UTI rates differ between PVP-coated and IAS catheters. 

The authors also discuss preclinical studies in which exposure to PVP affected sperm motility, viability and morphology. These findings raise questions for further investigation, particularly for people with spinal cord injuries who may already experience fertility difficulties. They do not, however, establish that PVP-coated catheters cause fertility problems in patients.

 
 

IAS technology: a potential alternative


IAS catheters are designed to provide intrinsic hydrophilicity without relying on a PVP coating. According to the paper, laboratory testing found friction levels comparable to several PVP-coated catheters and lower than those of uncoated catheters. Other preclinical studies suggest that IAS catheters may have less adhesive interaction with urethral tissue and leave less residual material in the urethral models examined.

These findings are promising, but the authors acknowledge that comparative clinical evidence remains limited. Further research is needed to determine whether the observed laboratory differences translate into meaningful improvements in patient outcomes.

Implications for nursing practice


The paper highlights the important role of continence and specialist nurses in supporting people who use intermittent catheters (IC). Nurses should consider the whole catheterisation experience, including navigation and withdrawal, rather than focusing solely on ease of insertion.
 

Practical considerations include:

  • Asking patients about sticking, pulling, discomfort, pain or bleeding during catheter removal
  • Exploring recurrent UTIs and other catheter-related problems as part of a wider clinical assessment
  • Considering individual factors such as dexterity, catheterisation technique, duration of use, comorbidities and previous urethral injury
  • Discussing catheter options with patients and supporting informed, individualised decisions
  • Recognising the limitations of the current evidence when explaining potential benefits and risks.

 

Conclusion


The paper argued that the performance of an intermittent catheter depends not only on its ability to reduce friction during insertion, but also on how its surface behaves during use and removal. Although PVP-coated catheters have improved the use of ISC for many people, preclinical findings raise questions about adhesion, residue formation and potential effects on urethral tissue. IAS technology offers a possible alternative, but further clinical research is required before its comparative benefits can be established.

For nurses, the key message is to listen to patients' experiences, recognise that comfort and urethral health deserve consideration alongside ease of insertion, and support individualised catheter choice through shared decision-making. 

Note: This article reviews a paper supported by Convatec. Several contributors to the original paper disclose professional relationships with catheter manufacturers.